| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 05/17/2006 | CN1773636A Water-base magnetic liquid and producing method thereof |
| 05/17/2006 | CN1771929A Treatment of pcp addiction and pcp addiction-related behavior |
| 05/17/2006 | CN1256734C Method of sterilizing radioactive seeds |
| 05/16/2006 | US7045606 Chelate compound containing ligand with steroids, enzymes, hapten and antibodies |
| 05/16/2006 | US7045605 genetic engineered antibodies, nucleic acids; anticancer agents |
| 05/16/2006 | US7045522 8-Azabicyclo[3.2.1]oct-2-ene and -octane derivatives technical field |
| 05/16/2006 | US7045503 Radiometal-binding peptide analogues |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045127 Human anti-epidermal growth factor receptor single-chain antibodies |
| 05/16/2006 | US7045116 Treatment of osteomyelitis with radiopharmaceuticals |
| 05/16/2006 | US7045115 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 05/11/2006 | WO2006050058A2 Methods of detection and therapy of inflamed tissues using immune modulation |
| 05/11/2006 | WO2005044313A3 Conjugates of angiotensin ii and an imaging moiety |
| 05/11/2006 | WO2005034912A3 Ferromagnetic particles and methods |
| 05/11/2006 | WO2004056323A3 Method of treating angiogenic tissue growth |
| 05/11/2006 | WO2004032857A3 Antibody therapy |
| 05/11/2006 | US20060100903 Method of enhancing the efficiency of a pharmaceutical business |
| 05/11/2006 | US20060100192 Heteroaryl diazacycloalkanes, their preparation and use |
| 05/11/2006 | US20060099144 Tumor association of MDL-1 and methods |
| 05/11/2006 | US20060099143 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition angiogenesis |
| 05/11/2006 | US20060099142 Cancer associated araf1 protein kinase and its uses |
| 05/11/2006 | US20060099141 Radiation sensitive liposomes |
| 05/11/2006 | CA2628298A1 Method to detect dopamine receptors in the functional d2high state |
| 05/10/2006 | EP1655367A1 Modulators of tissue regeneration |
| 05/10/2006 | EP1655287A1 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 05/10/2006 | EP1654005A2 Stable radiopharmaceutical compositions and methods for preparation |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | EP1154798B1 Molecules for the treatment and diagnosis of tumors |
| 05/10/2006 | EP0972055B1 METHOD FOR PRODUCING PURIFIED AND MARKED TSH RECEPTOR PREPARATIONS AND THE USE OF the corresponding PREPARATIONS IN DIAGNOSTICS |
| 05/10/2006 | EP0684843B1 TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING OF INFLAMMATION |
| 05/10/2006 | CN1771058A Microwave method for preparing radiolabelled gallium complexes |
| 05/10/2006 | CN1768862A Protein marked by Tc-99 capable of specifically combined with GnRH-receptor expressed cancer cell |
| 05/09/2006 | USRE39094 absorb light further in the red, optimizing tissue penetration and are retained in the skin for short time periods relative to other drugs used in photodynamic cancer therapy |
| 05/09/2006 | US7041851 Diagnosis; central nervous system disorders; psychological disorders |
| 05/09/2006 | US7041790 Fibrinogen binding moieties |
| 05/09/2006 | US7041653 Gene transcription and ionizing radiation: methods and compositions |
| 05/09/2006 | US7041046 Combination ionizing radiation and immunomodulator delivery devices and methods for inhibiting hyperplasia |
| 05/04/2006 | WO2006047214A2 Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer |
| 05/04/2006 | WO2006033714A3 Metal chelators and methods of their use |
| 05/04/2006 | WO2006003488A3 Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |
| 05/04/2006 | US20060094057 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 05/04/2006 | US20060093554 Galenical formulations |
| 05/04/2006 | US20060093553 Cd26-based therapies for cancers and immune disease |
| 05/04/2006 | US20060093552 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 05/04/2006 | US20060093551 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
| 05/04/2006 | CA2586474A1 Lamotrigine analogs |
| 05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
| 05/03/2006 | EP1651276A1 Emulsion particles for imaging and therapy and methods of use thereof |
| 05/03/2006 | EP1651201A1 Necrosis avid tracer agent |
| 05/03/2006 | EP0971899B1 Hexahydroindenopyridine compounds having antispermatogenic activity |
| 05/03/2006 | CN1768266A Methods for the purification of stable radioiodine conjugates |
| 05/03/2006 | CN1768047A Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers. |
| 05/03/2006 | CN1767860A Methods and compositions for administering therapeutic and diagnostic agents |
| 05/03/2006 | CN1767859A Improved radiometal complex compositions |
| 05/03/2006 | CN1767078A Preparation of radium-223, physically accepted preparation and kit |
| 05/03/2006 | CN1254276C Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 05/02/2006 | US7037647 Prostate-specific membrane antigen and uses thereof |
| 05/02/2006 | US7037487 Method for diagnosing lactose intolerance and diagnostic kit for performing the method |
| 05/02/2006 | US7037486 Labelled phosphoinositides and analogues |
| 05/02/2006 | CA2149529C Peptides and anti-sense peptides with broad neoplastic specificity |
| 04/27/2006 | WO2006043083A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy |
| 04/27/2006 | WO2005117848A9 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 04/27/2006 | WO2005105159A3 Contrast agents for myocardial perfusion imaging |
| 04/27/2006 | WO2005079757A3 Therapeutic agent carrier compositions |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | US20060088471 Compounds for enzyme inhibition |
| 04/27/2006 | CA2583367A1 Cytotoxic formulation for combination therapy |
| 04/26/2006 | EP1648512A2 Anti-cd19 antibodies |
| 04/26/2006 | EP1648510A2 Rg1 antibodies and uses thereof |
| 04/26/2006 | EP1648381A2 Magnetic nanoparticle compositions, and methods related thereto |
| 04/26/2006 | EP0841949B1 Use of saccharide conjugates |
| 04/26/2006 | CN1764670A Compound having affinity with calcified tissue |
| 04/26/2006 | CN1762499A Medicament box of 2beta-[N,N'-di(2-mercaptoethyl) ethylene diamine] methyl-3 beta-(4- chlorphenyl) tropane |
| 04/25/2006 | US7034121 Antibodies against CTLA4 |
| 04/25/2006 | US7034034 Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives |
| 04/25/2006 | US7033798 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment |
| 04/25/2006 | US7033573 Drawing a small sample of cerebral spinal fluid (CSF), blood and urine; testing for concentrations of glucose and for concentrations of a component of CSF; infusing component of CSF into vein; testing, comparing glucose concentration |
| 04/25/2006 | US7033572 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/25/2006 | US7033571 Multiple stimulus reversible hydrogels |
| 04/20/2006 | WO2006020156A3 Heterocyclic dye compounds for in vivo imaging and diagnosis of alzheimer’s disease |
| 04/20/2006 | WO2006014589A3 Virtual colonoscopy with radiolabeled phospholipid ether analogs |
| 04/20/2006 | WO2005120588A3 Peptides delivered to cell nuclei |
| 04/20/2006 | WO2005054128A3 Method and apparatus for synthesis of [11c] phosgen using concentrated [11c] carbon monoxide with uv light |
| 04/20/2006 | US20060084610 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 04/20/2006 | US20060084124 Localization of A2B AdoR on human normal and diseased tissue: the use of anti-A2B antibody to diagnose and treat human tumors |
| 04/20/2006 | US20060083745 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 04/20/2006 | US20060083685 Opioid metallopeptide compositions and methods |
| 04/20/2006 | US20060083684 Method of radio-labelling biomolecules |
| 04/20/2006 | US20060083683 Cysteine residue within the hinge region of the antibody fragment; a disulfide bridge within the hinge region is avoided by substituting another amino acid for the corresponding cysteine residue in the opposite chain of the fragment; conjugate binds the same antigen as the unmodified parental molecule |
| 04/20/2006 | US20060083682 Novel methods of cancer therapy targeted against a cancer stemline |
| 04/20/2006 | US20060083681 Compounds for myocardial perfusion imaging |
| 04/20/2006 | US20060083680 Diphenyl ether derivatives and their use for imaging serotonin transporters |
| 04/20/2006 | US20060083679 Agents with selective K-opioid receptor affinity |
| 04/20/2006 | US20060083678 Radio-labeled compounds, compositions, and methods of making the same |
| 04/20/2006 | US20060083677 Solid-phase fluorination of benzothiazoles |
| 04/20/2006 | US20060083676 For marking and identifying metabotropic glutamate receptor sites and for imaging an organ; in particular non-competitive mGlu1 receptor ligands |
| 04/20/2006 | DE3991505B4 Somatostatinpeptide, deren Analoga oder Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen Somatostatin peptides, their analogues or derivatives, to processes for their preparation and pharmaceutical compositions containing them |
| 04/20/2006 | CA2582919A1 Immunotherapy of autoimmune disorders |
| 04/19/2006 | EP1207911B1 Composition comprising radiopharmaceutical metal complexes in silica-coated containers |
| 04/19/2006 | EP1204650B1 Substituted 2-arylbenzazole compounds and their use as antitumour agents |